By including the previously mentioned patients 1 and 2 with MDS/MPN, BM aspirate samples were available for screening the presence of exon-12 NPM1 mutations by qualitative PCR analysis in 135 cases (Table 1). Here, NPM1 is linked to myeloproliferative disorder.